The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010
Open accessAbstract
IMPORTANCE: Type 1 diabetes has historically been associated with a significant reduction in life expectancy. Major advances in treatment of type 1 diabetes have occurred in the past 3 decades. Contemporary estimates of the effect of type 1 diabetes on life expectancy are needed. OBJECTIVE: To examine current life expectancy in people with and without type 1 diabetes in Scotland. We also examined whether any loss of life expectancy in patients with type 1 diabetes is confined to those who develop kidney disease. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort of all individuals alive in Scotland with type 1 diabetes who were aged 20 years or older from 2008 through 2010 and were in a nationwide register (n=24,691 contributing 67,712 person-years and 1043 deaths). MAIN OUTCOMES AND MEASURES: Differences in life expectancy between those with and those without type 1 diabetes and the percentage of the difference due to various causes. RESULTS: Life expectancy at an attained age of 20 years was an additional 46.2 years among men with type 1 diabetes and 57.3 years among men without it, an estimated loss in life expectancy with diabetes of 11.1 years (95% CI, 10.1-12.1). Life expectancy from age 20 years was an additional 48.1 years among women with type 1 diabetes and 61.0 years among women without it, an estimated loss with diabetes of 12.9 years (95% CI, 11.7-14.1). Even among those with type 1 diabetes with an estimated glomerular filtration rate of 90 mL/min/1.73 m2 or higher, life expectancy was reduced (49.0 years in men, 53.1 years in women) giving an estimated loss from age 20 years of 8.3 years (95% CI, 6.5-10.1) for men and 7.9 years (95% CI, 5.5-10.3) for women. Overall, the largest percentage of the estimated loss in life expectancy was related to ischemic heart disease (36% in men, 31% in women) but death from diabetic coma or ketoacidosis was associated with the largest percentage of the estimated loss occurring before age 50 years (29.4% in men, 21.7% in women). CONCLUSIONS AND RELEVANCE: Estimated life expectancy for patients with type 1 diabetes in Scotland based on data from 2008 through 2010 indicated an estimated loss of life expectancy at age 20 years of approximately 11 years for men and 13 years for women compared with the general population without type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cardiovascular disease remains the major cause of premature morbidity and mortality, with data119,120 suggesting an 8–13-year shorter life expectancy for people with type 1 diabetes than for healthy individuals.”
From Type 1 diabetes (2018) · cites this paper as [120]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (121-123).”
From 13. Older Adults: Standards of Care in Diabetes—2024 (2024) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of these people over 65 years of age is growing (136-138).”
From 13. Older Adults: Standards of Care in Diabetes—2025 (2025) · cites this paper as [136]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, mortality rates in 2008–2010 increased from 31.9 and 24.2 per 1,000 person-years in men and women, respectively, with T1DM who were aged 60–64 years to 142.7 in men and 171.3 in women aged ≥80 years39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In Scotland, reductions in life expectancy for people with T1DM aged 60–64 years were 5.6 years and 7.1 years for men and women, respectively39.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [39]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Due in part to the success of modern diabetes management, people with type 1 diabetes are living longer, and the population of people over 65 years with type 1 diabetes is growing (154–156).”
From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [154]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2000) · doi:10.32614/r.manuals · Cited by 355,893
Patterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Introduction to Stochastic Processes in Biostatistics
Bartlett, M. S., & Chiang, C. L. (1969) · Revue de l Institut International de Statistique / Review of the International Statistical Institute · doi:10.2307/1402301 · Cited by 684
The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes
Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., et al. (2009) · Diabetes · doi:10.2337/db08-1543 · Cited by 638
Measuring and explaining the change in life expectancies
Arriaga, E. E. (1984) · Demography · doi:10.2307/2061029 · Cited by 630
Type 1 Diabetes Mellitus and Cardiovascular Disease
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 516
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 444
High Risk of Cardiovascular Disease in Patients With Type 1 Diabetes in the U.K.
Soedamah‐Muthu, S. S., Fuller, J., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1433 · Cited by 395
Self-citationLivingstone, S. J., Looker, H. C., Hothersall, E. J., Wild, S. H., Lindsay, R. S., Chalmers, J., Cleland, S. J., Leese, G., McKnight, J. A., Morris, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001321 · Cited by 356
Self-citationOrchard, T. J., Secrest, A. M., Miller, R. G., & Costacou, T. (2010) · Diabetologia · doi:10.1007/s00125-010-1860-3 · Cited by 317
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 622
Walker, J. J., Colhoun, H. M., Livingstone, S. J., McCrimmon, R. J., Petrie, J. R., Sattar, N. A., & Wild, S. H. (2017) · Diabetologia · doi:10.1007/s00125-017-4478-x · Cited by 60
Self-citationIL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
Greenbaum, C. J., Serti, E., Lambert, K., Weiner, L. J., Kanaparthi, S., Lord, S. M., Gitelman, S. E., Wilson, D. M., Gaglia, J. L., Griffin, K., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.150074 · Cited by 62
Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016
Mair, C., Wulaningsih, W., Jeyam, A., McGurnaghan, S. J., Blackbourn, L. A. K., Kennon, B., Leese, G., Lindsay, R. S., McCrimmon, R. J., McKnight, J. A., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4900-7 · Cited by 60
Self-citationThe epidemiology of type 1 diabetes mellitus in older adults
Tomic, D., Harding, J. L., Jenkins, A. J., Shaw, J. E., & Magliano, D. J. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01046-z · Cited by 58
Bhutta, Z. A., Salam, R. A., Gomber, A., Lewis-Watts, L., Narang, T., Mbanya, J. C., & Alleyne, G. A. O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02247-9 · Cited by 61
Huerta‐Uribe, N., Ramírez‐Vélez, R., Izquierdo, M., & García‐Hermoso, A. (2022) · Sports Medicine · doi:10.1007/s40279-022-01741-9 · Cited by 58
Arffman, M., Hakkarainen, P., Keskimäki, I., Oksanen, T., & Sund, R. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110580 · Cited by 58
Treff, N. R., Eccles, J., Marin, D., Messick, E., Lello, L., Gerber, J., Xu, J. L., & Tellier, L. C. A. M. (2020) · Genes · doi:10.3390/genes11060648 · Cited by 57
Meng, H., Zhang, A., Liang, Y., Hao, J., Zhang, X., & Lu, J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2983 · Cited by 56
Bone health in subjects with type 1 diabetes for more than 50 years
Maddaloni, E., D’Eon, S., Hastings, S. M., TINSLEY, L. J., Napoli, N., Khamaisi, M., Bouxsein, M., Fouda, S. M. R., & Keenan, H. A. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-0973-2 · Cited by 55
Development and validation of a cardiovascular risk prediction model in type 1 diabetes
McGurnaghan, S. J., McKeigue, P. M., Read, S. H., Franzen, S., Svensson, A.-M., Colombo, M., Livingstone, S., Farran, B., Caparrotta, T. M., Blackbourn, L. A. K., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05478-4 · Cited by 53
Self-citationCosts of Public Health Screening of Children for Presymptomatic Type 1 Diabetes in Bavaria, Germany
Karl, F. M., Winkler, C., Ziegler, A., Laxy, M., & Achenbach, P. (2022) · Diabetes Care · doi:10.2337/dc21-1648 · Cited by 53
Biomarker panels associated with progression of renal disease in type 1 diabetes
Colombo, M., Valo, E., McGurnaghan, S. J., Sandholm, N., Blackbourn, L. A. K., Dalton, R. N., Dunger, D. B., Groop, P., McKeigue, P., Forsblom, C. M., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4915-0 · Cited by 53
Self-citationIn Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
Zaccardi, F., Rizzi, A., Petrucci, G., Ciaffardini, F., Tanese, L., Pagliaccia, F., Cavalca, V., Ciminello, A., Habib, A., Squellerio, I., et al. (2016) · Diabetes · doi:10.2337/db15-0936 · Cited by 53
Why is the Incidence of Type 1 Diabetes Increasing?
Abela, A. G., & Fava, S. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210503133747 · Cited by 55
Chhasatia, R., Sweetman, M. J., Harding, F. J., Waibel, M., Kay, T., Thomas, H. E., Loudovaris, T., & Voelcker, N. H. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.01.004 · Cited by 50
Avogaro, A., Fadini, G. P., & Prato, S. D. (2019) · Diabetes Care · doi:10.2337/dc19-1410 · Cited by 50
Commemorating insulin's centennial: engineering insulin pharmacology towards physiology
Kurtzhals, P., Nishimura, E., Haahr, H. L., Høeg-Jensen, T., Johansson, E., Madsen, P., Sturis, J., & Kjeldsen, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.05.005 · Cited by 51
Nakayasu, E. S., Bramer, L., Ansong, C. K., Schepmoes, A., Fillmore, T., Gritsenko, M., Clauss, T. R., Gao, Y., Piehowski, P., Stanfill, B., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101093 · Cited by 49
Post‐translational modifications of the cardiac proteome in diabetes and heart failure
Wende, A. R. (2015) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500052 · Cited by 50
New-onset diabetes after pancreatoduodenectomy: A systematic review and meta-analysis
Scholten, L., Mungroop, T. H., Haijtink, S. A. L., Issa, Y., van Rijssen, L. B., Koerkamp, B. G., van Eijck, C. H. J., Busch, O. R., DeVries, J. H., & Besselink, M. G. (2018) · Surgery · doi:10.1016/j.surg.2018.01.024 · Cited by 47
Weinstock, R. S., Schütz-Fuhrmann, I., Connor, C. G., Hermann, J. M., Maahs, D. M., Schütt, M., Agarwal, S., Hofer, S. E., Beck, R. W., & Holl, R. W. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.09.024 · Cited by 47
Metformin and cardiorenal outcomes in diabetes: A reappraisal
Petrie, J. R., Rossing, P. R., & Campbell, I. W. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13984 · Cited by 47
Self-citationAll-cause mortality in a nationwide cohort of childhood-onset diabetes in Norway 1973–2013
Gagnum, V., Stene, L. C., Sandvik, L., Fagerland, M. W., Njølstad, P. R., Joner, G., & Skrivarhaug, T. (2015) · Diabetologia · doi:10.1007/s00125-015-3623-7 · Cited by 46
Excess Cardiovascular Risk in Type 1 Diabetes Mellitus
Petrie, J. R., & Sattar, N. A. (2019) · Circulation · doi:10.1161/circulationaha.118.038137 · Cited by 46
Self-citationEl Masri, D., Ghosh, S., & Jaber, L. A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.004 · Cited by 45
Diagnosis and management of type 1 diabetes in adults: summary of updated NICE guidance
Amiel, S. A., Pursey, N., Higgins, B., & Dawoud, D. (2015) · BMJ · doi:10.1136/bmj.h4188 · Cited by 45
Bogdanou, D., Penna-Martinez, M., Filmann, N., Chung, T. L., Moran-Auth, Y., Wehrle, J., Cappel, C., Huenecke, S., Herrmann, E. M., Koehl, U., et al. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2865 · Cited by 45
Charmet, R., Duffy, S., Keshavarzi, S., Gyorgy, B., Marre, M., Rossing, P. R., McKnight, A. J., Maxwell, A. P., Ahluwalia, T. S., Paterson, A. D., et al. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0705-0 · Cited by 44
Insulin‐dependent diabetes mellitus in older adults: Current status and future prospects
Ikegami, H., Hiromine, Y., & Noso, S. (2022) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.14414 · Cited by 47
Tachkov, K., Mitov, K., Koleva, Y. N., Mitkova, Z. E., Kamusheva, M., Dimitrova, M. J., Petkova, V. B., Savova, A., Doneva, M., Tcarukciev, D., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232815 · Cited by 43
Herold, K. C., Reynolds, J., Dziura, J. D., Baidal, D. A., Gaglia, J. L., Gitelman, S. E., Gottlieb, P. A., Marks, J., Philipson, L. H., Pop‐Busui, R., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14121 · Cited by 44
Wang, J., Liu, F., Kong, R., & Han, X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.890273 · Cited by 42
Witham, M. D., Granic, A., Pearson, E. R., Robinson, S. M., & Sayer, A. A. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01042-4 · Cited by 45
Scaramuzza, A. E., Giani, E., Redaelli, F. C., Ungheri, S., Macedoni, M., Giudici, V., Bosetti, A., Ferrari, M., & Zuccotti, G. (2015) · Journal of Diabetes Research · doi:10.1155/2015/474561 · Cited by 42
Marcovecchio, M. L., Chiesa, S. T., Armitage, J., Daneman, D., Donaghue, K. C., Jones, T. W., Mahmud, F. H., Marshall, S. M., Neil, H. A. W., Dalton, R. N., et al. (2018) · Diabetes Care · doi:10.2337/dc18-1125 · Cited by 43
Disparities in Care Delivery and Outcomes in Young Adults With Diabetes
Agarwal, S., Hilliard, M. E., & Butler, A. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1037-x · Cited by 43
Karamanakos, G., Kokkinos, A. D., Dalamaga, Μ., & Liatis, S. (2022) · Current Obesity Reports · doi:10.1007/s13679-022-00477-x · Cited by 44
Manell, E., Hedenqvist, P., Svensson, A. C., & Jensen‐Waern, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148896 · Cited by 42
Treatment of dyslipidemia in diabetes: recent advances and remaining questions
Chait, A., & Goldberg, I. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0942-8 · Cited by 40
Coronary artery disease and diabetes mellitus
Al-Nozha, M. M., Ismail, H. M., & Nozha, O. M. A. (2016) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2016.03.005 · Cited by 43
Groop, P., Thomas, M. C., Feodoroff, M., Forsblom, C. M., & Harjutsalo, V. (2018) · Diabetes Care · doi:10.2337/dc17-1618 · Cited by 40
Eryd, S. A., Svensson, A. ‐., Franzén, S., Eliasson, B., Nilsson, P. M., & Guðbjörnsdóttir, S. (2016) · Diabetic Medicine · doi:10.1111/dme.13266 · Cited by 40
Bjerg, L., Hulman, A., Carstensen, B., Charles, M., Witte, D. R., & Jørgensen, M. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4812-6 · Cited by 39
Screening and Prevention of Type 1 Diabetes: Where Are We?
Simmons, K. M., & Sims, E. K. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad328 · Cited by 41
Petrie, J. R., Chaturvedi, N., Ford, I., HRAMIAK, I. M., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., Klein, R., Ooi, T. C., Rossing, P. R., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12840 · Cited by 39
Self-citationWITHDRAWN: Reprint of: Classification of diabetes mellitus
Adler, A., Bennett, P., Chair, S. C., Gregg, E., Venkat Narayan, K. M., Schmidt, M. I., Sobngwi, E., Tajima, N., Tandon, N., Unwin, N., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108972 · Cited by 38
Self-citationRetractedAgarwal, S., Crespo-Ramos, G., Leung, S. L., FINNAN, M., Park, T., McCurdy, K., Gonzalez, J. S., & Long, J. A. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0496 · Cited by 38
Shada, A. L., Nielsen, A., Marowski, S., Helm, M. C., Funk, L. M., Kastenmeier, A. S., Lidor, A. O., & Gould, J. C. (2018) · Surgery · doi:10.1016/j.surg.2018.04.043 · Cited by 38
Components of diabetes prevalence in Denmark 1996–2016 and future trends until 2030
Carstensen, B., Rønn, P. F., & Jørgensen, M. E. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001064 · Cited by 38
Giri, K. R., de Beaurepaire, L., Jégou, D., Lavy, M., Mosser, M., Dupont, A., Fleurisson, R., Dubreil, L., Collot, M., Endert, P. V., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01814 · Cited by 38
Zhou, L., He, X., Cai, P., Li, T., Peng, R., Dang, J., Li, Y., Li, H., Huang, F., Shi, G., et al. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00623-2 · Cited by 38
LACY, M. E., Moran, C., Gilsanz, P., Beeri, M. S., Karter, A. J., & Whitmer, R. A. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002557 · Cited by 39
Type 1 diabetes: A new vision of the disease based on endotypes
Weston, C. S., Boehm, B. O., & Pozzilli, P. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3770 · Cited by 40
Ou, H., Yang, C., Wang, J., Hwang, J., & Wu, J. (2016) · Value in Health · doi:10.1016/j.jval.2016.05.017 · Cited by 37
Marrero, D. G., Hilliard, M. E., Maahs, D. M., McAuliffe‐Fogarty, A. H., & Hunter, C. M. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.05.016 · Cited by 37
Garrett, C. J., Choudhary, P., Amiel, S. A., Fonagy, P., & Ismail, K. (2019) · Diabetic Medicine · doi:10.1111/dme.14109 · Cited by 37
Krentz, N. A. J., Shea, L. D., Huising, M. O., & Shaw, J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00170-4 · Cited by 39
Spinetti, G., Mutoli, M., Greco, S., Riccio, F., Ben‐Aicha, S., Kenneweg, F., Jusić, A., de Gonzalo‐Calvo, D., Nossent, A. Y., Novella, S., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01842-3 · Cited by 38
Asiri, A., Qarni, A. A. A., & Bakillah, A. (2024) · Diagnostics · doi:10.3390/diagnostics14192132 · Cited by 37
Explaining the increased mortality in type 1 diabetes
Mameli, C. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.889 · Cited by 37
Automated Insulin Delivery for Young People with Type 1 Diabetes and Elevated A1c
Boucsein, A., Zhou, Y., Michaels, V. R., Haszard, J. J., Jefferies, C., Wiltshire, E. J., Paul, R. G., Parry‐Strong, A., Pasha, M., Petrovski, G., et al. (2024) · NEJM Evidence · doi:10.1056/evidoa2400185 · Cited by 34
Predicting renal disease progression in a large contemporary cohort with type 1 diabetes mellitus
Colombo, M., McGurnaghan, S. J., Bell, S., MacKenzie, F., Patrick, A. W., Petrie, J. R., McKnight, J. A., MacRury, S. M., Traynor, J. P., Metcalfe, W., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05052-z · Cited by 34
Self-citationPreventing Cardiovascular Complications in Type 1 Diabetes: The Need for a Lifetime Approach
Chiesa, S. T., & Marcovecchio, M. L. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.696499 · Cited by 36
Semova, I., Levenson, A. E., Krawczyk, J., Bullock, K., Williams, K. A., Wadwa, R. P., Shah, A. S., Khoury, P. R., Kimball, T. R., Urbina, E. M., et al. (2019) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2019.09.008 · Cited by 33
The changing face of paediatric diabetes
SHAH, A. S., & Nadeau, K. J. (2020) · Diabetologia · doi:10.1007/s00125-019-05075-6 · Cited by 36
Exercise on Progenitor Cells in Healthy Subjects and Patients with Type 1 Diabetes
Waclawovsky, G., Umpierre, D., Figueira, F. R., de Lima, E. D. S., Alegretti, A. P., Schneider, L., Matte, U. S., Rodrigues, T. D. C., & Schaan, B. D. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000764 · Cited by 33
Spark, T. L., Maahs, D. M., Bishop, F. K., Snell‐Bergeon, J. K., & Wadwa, R. P. (2016) · International Journal of Pediatric Endocrinology · doi:10.1186/s13633-016-0026-6 · Cited by 33
Ray, S. L., Coulson, D. J., Yeoh, M. L. Y., Tamara, A., Latief, J. S., Bakhashab, S., & Weaver, J. U. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197217 · Cited by 35
Myostatin inhibition therapy for insulin-deficient type 1 diabetes
Coleman, S. K., Rebalka, I. A., D’Souza, D. M., Deodhare, N., Desjardins, E. M., & Hawke, T. J. (2016) · Scientific Reports · doi:10.1038/srep32495 · Cited by 34
A new strategy for vascular complications in young people with type 1 diabetes mellitus
on behalf of the Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT) study group, Marcovecchio, M. L., Dalton, R. N., Daneman, D., Deanfield, J. E., Jones, T. W., Neil, H. A. W., & Dunger, D. B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0198-2 · Cited by 33
Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes
Katz, M. L., Kollman, C., Dougher, C. E., Mubasher, M., & Laffel, L. M. (2016) · Diabetes Care · doi:10.2337/dc16-0430 · Cited by 31
Thomas, M., Harjutsalo, V., Feodoroff, M., Forsblom, C., Gordin, D., & Groop, P.-H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz003 · Cited by 30
Marella, S., & Tollamadugu, N. V. K. V. P. (2018) · IET Nanobiotechnology · doi:10.1049/iet-nbt.2017.0242 · Cited by 30
Gonna, H., & Ray, K. K. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13691 · Cited by 30
Targeting Glycoproteins as a therapeutic strategy for diabetes mellitus and its complications
Naseri, R., Navabi, S. J., Samimi, Z., Mishra, A. P., Nigam, M., Chandra, H., Olatunde, A., Tijjani, H., Morais‐Urano, R. P., & Farzaei, M. H. (2020) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-020-00327-y · Cited by 31
Type 1 diabetes mellitus prevention: present and future
Henriques, F. L., Buckle, I., & Forbes, J. M. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01128-6 · Cited by 32
Luo, D., Gu, W., Bao, Y., Cai, X., Lu, Y., Li, R., Wang, Y., & Li, M. (2021) · Journal of Clinical Nursing · doi:10.1111/jocn.15739 · Cited by 29
Inhibition of polyamine biosynthesis preserves β cell function in type 1 diabetes
Sims, E. K., Kulkarni, A., Hull, A., Woerner, S. E., Cabrera, S. M., Mastrandrea, L. D., Hammoud, B., Sarkar, S., Nakayasu, E. S., Mastracci, T. L., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101261 · Cited by 31
Andelin, M., Kropff, J., Matuleviciene, V., Joseph, J. I., Attvall, S., Theodorsson, E., Hirsch, I. B., Imberg, H., Dahlqvist, S., Klonoff, D. C., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815626724 · Cited by 29
Zhao, J. V., Luo, S., & Schooling, C. M. (2019) · Communications Biology · doi:10.1038/s42003-019-0579-z · Cited by 30
Llauradó, G., Cano, A., Albert, L., Ballesta, S., Mazarico, I., Luchtenberg, M. F., González-Sastre, M., Megía, A., Simó, R., Vendrell, J. J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220206 · Cited by 28
Mantovani, A., Morieri, M. L., Palmisano, L., Masulli, M., Cossu, E., Baroni, M. G., Bonomo, K., Cimini, F. A., Cavallo, M. G., Buzzetti, R., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01945-x · Cited by 29
Jacobsen, L. M., & Schatz, D. (2026) · JAMA · doi:10.1001/jama.2026.0048 · Cited by 30
Lind, M., Polonsky, W. H., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Pehrsson, N.-G., & Moström, P. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816642578 · Cited by 27
Ahmed, M. O., Byrne, R., Pazderska, A., Segurado, R., Guo, W., Gunness, A., Frizelle, I. M., Sherlock, M., Ahmed, K. S., McGowan, A., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05320-3 · Cited by 28
Chen, X., Zhou, P., Zhang, M., Xu, Z., Zhao, Z., Lü, W., Chen, L., Luo, F., Chen, T., & Sun, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651589 · Cited by 27
Experience of living with type 1 diabetes in a low-income country: a qualitative study from Liberia
Adler, A. J., Trujillo, C., Schwartz, L. N., Drown, L., Pierre, J., Noble, C., Allison, T., Cook, R. L., Randolph, C., & Bukhman, G. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-049738 · Cited by 29
Hallström, S., Wijkman, M. O., Ludvigsson, J., Ekman, P., Pfeffer, M. A., Wedel, H., Rosengren, A., & Lind, M. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100469 · Cited by 30
Ahmed, F. W., Bakhashab, S., Bastaman, I. T., Crossland, R. E., Glanville, M., & Weaver, J. U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103242 · Cited by 26
Abdraimova, A., Besançon, S., Portocarrero, J., Ramaiya, K. L., Dunganova, A., Ewen, M. A., Hogerzeil, H. V., Lazo‐Porras, M., Laing, R. O., Lepeska, M., et al. (2022) · Diabetic Medicine · doi:10.1111/dme.14891 · Cited by 26
McGurnaghan, S. J., Blackbourn, L. A. K., Caparrotta, T. M., Mellor, J., Barnett, A. L., Collier, A., Sattar, N. A., McKnight, J. A., Petrie, J. R., Philip, S., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-063046 · Cited by 26
Self-citationFelton, J. L., Griffin, K., Oram, R. A., Speake, C., Long, S. A., Önengüt-Gümüşcü, S., Rich, S. S., Monaco, G. S. F., Evans‐Molina, C., DiMeglio, L. A., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00357-y · Cited by 27
The Experience of Partners of Adults with Type 1 Diabetes: an Integrative Review
Whittemore, R., Delvy, R., & McCarthy, M. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0986-4 · Cited by 26
Current advanced therapy cell-based medicinal products for type-1-diabetes treatment
Cañibano-Hernández, A., del Burgo, L. S., Espona‐Noguera, A., Ciriza, J., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.041 · Cited by 26
Zhang, P., Schmidt, D. C., White, J., & Mulvaney, S. A. (2018) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi.2018.00015 · Cited by 26
Jones, S., Khanolkar, A. R., Gevers, E. F., Stephenson, T. J., & Amin, R. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000625 · Cited by 30
O’Reilly, J. E., Jeyam, A., Caparrotta, T. M., Mellor, J., Hohn, A., McKeigue, P. M., McGurnaghan, S. J., Blackbourn, L. A. K., McCrimmon, R., Wild, S. H., et al. (2021) · Diabetes Care · doi:10.2337/dc21-0689 · Cited by 25
Self-citationRathsman, B., Haas, J., Persson, M., Ludvigsson, J., Svensson, A. ‐., Lind, M., Franko, M. A., & Nyström, T. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13212 · Cited by 28
Mellor, J., Jiang, W., Fleming, A., McGurnaghan, S. J., Blackbourn, L. A. K., Styles, C., Storkey, A., McKeigue, P., & Colhoun, H. M. (2023) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2023.105072 · Cited by 25
Self-citation
Metadata
- Authors
- Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., McKnight, J. A., Morris, A. D., Pearson, D. W. M., Petrie, J. R., Philip, S., Sattar, N. A., Traynor, J. P., & Colhoun, H. M.
- Affiliations
- University of Dundee (GB)
- University of Glasgow (GB)
- University of Edinburgh (GB)
- Raigmore Hospital (GB)
- Borders General Hospital (GB)
- Scottish Renal Registry, Paisley, Scotland
- Western General Hospital (GB)
- NHS Grampian (GB)
- ORCID
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-01-06
- Volume
- 313
- Issue
- 1
- Pages
- 37
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- PMC
- PMC4426486
- OpenAlex
- W1965748339
- Cited by
- 621
- References
- 19
- Citations by year
- 2026: 39 · 2025: 46 · 2024: 49 · 2023: 55 · 2022: 66 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 51 · 2017: 39 · 2016: 48 · 2015: 42
- FWCI
- 52.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Funders
- Wellcome Trust (086113)
- Diabetes UK (10/0004010)
- Medical Research Council (MR/M501633/1, MR/K007017/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, life expectancy, life expectancy loss, kidney disease, estimated glomerular filtration rate, ischemic heart disease, diabetic ketoacidosis, diabetic coma, sex differences, causes of death, Scotland, life expectancy at age 65
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Type 1, Diabetic Coma, Female, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, Scotland, Sex Factors, Myocardial Ischemia, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
